{"id":848904,"date":"2025-05-08T06:04:16","date_gmt":"2025-05-08T10:04:16","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-4th-quarter-and-fiscal-year-2025-earnings-release-available-on-investor-relations-website\/"},"modified":"2025-05-08T06:04:16","modified_gmt":"2025-05-08T10:04:16","slug":"haemonetics-4th-quarter-and-fiscal-year-2025-earnings-release-available-on-investor-relations-website","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-4th-quarter-and-fiscal-year-2025-earnings-release-available-on-investor-relations-website\/","title":{"rendered":"Haemonetics 4th Quarter and Fiscal Year 2025 Earnings Release Available on Investor Relations Website"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p class=\"prntac\">\n        <b><br \/>\n          <i>Financial release accessible online<\/i><br \/>\n        <\/b>\n      <\/p>\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">BOSTON<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">May 8, 2025<\/span><\/span> \/PRNewswire\/ &#8212;\u00a0Haemonetics Corporation (NYSE: HAE) announced that financial results for its fourth quarter and fiscal year 2025, which ended <span class=\"xn-chron\">March 29, 2025<\/span>, are available on its Investor Relations website.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/351568\/Haemonetics_Corporation_Logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/351568\/Haemonetics_Corporation_Logo.jpg\" title=\"\" alt=\"\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at <span class=\"xn-chron\">8:00 a.m. ET<\/span> on <span class=\"xn-chron\">May 8, 2025<\/span>. The conference call and webcast can be accessed with the following information:<\/p>\n<ul type=\"disc\">\n<li>Teleconference link:<\/li>\n<li>\n          <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4422649-1&amp;h=2821770233&amp;u=https%3A%2F%2Fregister-conf.media-server.com%2Fregister%2FBI8b22e12b203a4693bead05f6d9f68d5d&amp;a=https%3A%2F%2Fregister-conf.media-server.com%2Fregister%2FBI8b22e12b203a4693bead05f6d9f68d5d\" target=\"_blank\" rel=\"nofollow\">https:\/\/register-conf.media-server.com\/register\/BI8b22e12b203a4693bead05f6d9f68d5d<\/a>\n        <\/li>\n<li>Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.<\/li>\n<li>A live webcast of the call can be accessed on Haemonetics&#8217; investor relations website or via the following link: <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4422649-1&amp;h=3669649192&amp;u=https%3A%2F%2Fedge.media-server.com%2Fmmc%2Fp%2F4z9yixt9&amp;a=https%3A%2F%2Fedge.media-server.com%2Fmmc%2Fp%2F4z9yixt9\" target=\"_blank\" rel=\"nofollow\">https:\/\/edge.media-server.com\/mmc\/p\/4z9yixt9<\/a><\/li>\n<\/ul>\n<p>In addition, the Company has posted to its Investor Relations website the earnings release and certain supplemental tables that will be referenced during the call and include additional information supporting fiscal 2026 total Company and Hospital reported and organic revenue growth guidance.<\/p>\n<p>Direct link to 4Q FY25 Earnings Release:<br \/><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4422649-1&amp;h=1616039999&amp;u=https%3A%2F%2Fhaemonetics.gcs-web.com%2Fstatic-files%2F89295437-34ea-473c-ae6e-409a07328239&amp;a=https%3A%2F%2Fhaemonetics.gcs-web.com%2Fstatic-files%2F89295437-34ea-473c-ae6e-409a07328239\" target=\"_blank\" rel=\"nofollow\">https:\/\/haemonetics.gcs-web.com\/static-files\/89295437-34ea-473c-ae6e-409a07328239<\/a><\/p>\n<p>Direct link to Hospital Reported and Organic Revenue Growth Guidance Supplemental Tables:<br \/><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4422649-1&amp;h=40274171&amp;u=https%3A%2F%2Fhaemonetics.gcs-web.com%2Fstatic-files%2F320de990-2769-4b30-beca-eff1ca68bad1&amp;a=https%3A%2F%2Fhaemonetics.gcs-web.com%2Fstatic-files%2F320de990-2769-4b30-beca-eff1ca68bad1\" target=\"_blank\" rel=\"nofollow\">https:\/\/haemonetics.gcs-web.com\/static-files\/320de990-2769-4b30-beca-eff1ca68bad1<\/a>\u00a0<\/p>\n<p>A replay of the conference call and webcast will be available for one year beginning on <span class=\"xn-chron\">May 8, 2025<\/span>, at <span class=\"xn-chron\">11:00 a.m. ET<\/span> using the conference call webcast link provided in this press release.<\/p>\n<p>\n        <b>ABOUT HAEMONETICS<br \/><\/b>Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4422649-1&amp;h=3379856177&amp;u=https%3A%2F%2Fwww.haemonetics.com%2F&amp;a=www.haemonetics.com\" target=\"_blank\" rel=\"nofollow\">www.haemonetics.com<\/a>.<\/p>\n<div>\n<table border=\"0\" cellspacing=\"0\" cellpadding=\"1\" class=\"prnbcc\">\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\"><br \/>\n                  <b>Investor Contacts:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/b><br \/>\n                <\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n              \n            <\/td>\n<\/tr>\n<tr>\n<td class=\"prnpr2 prnpl2 prnsbtb1 prnrbrb1 prnsbbb1 prnsblb1\" colspan=\"1\" rowspan=\"1\" nowrap=\"nowrap\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">Olga Guyette, Vice President-Investor Relations &amp; Treasury\u00a0 \u00a0 \u00a0 \u00a0 \u00a0<\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">David Trenk, Manager-Investor Relations<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">(781) 356-9763\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0<\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">(203) 733-4987<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\"><br \/>\n                  <a href=\"mailto:olga.guyette@haemonetics.com\" target=\"_blank\" class=\"prnews_a\" rel=\"nofollow\">olga.guyette@haemonetics.com<\/a>\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0<\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\"><br \/>\n                  <a href=\"mailto:david.trenk@haemonetics.com\" target=\"_blank\" class=\"prnews_a\" rel=\"nofollow\">david.trenk@haemonetics.com<\/a>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">\u00a0<\/span>\n              <\/p>\n<p class=\"prnml4\">\n                <span class=\"prnews_span\"><br \/>\n                  <b>Media Contact:<\/b>\u00a0 \u00a0 \u00a0 \u00a0 \u00a0<br \/>Josh Gitelson, Sr. Director-Global Communications\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <br \/>(781) 356-9776<br \/><a href=\"mailto:josh.gitelson@haemonetics.com\" target=\"_blank\" class=\"prnews_a\" rel=\"nofollow\">josh.gitelson@haemonetics.com<\/a><\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n              \n            <\/td>\n<\/tr>\n<\/table><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NE82651&amp;sd=2025-05-08\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/haemonetics-4th-quarter-and-fiscal-year-2025-earnings-release-available-on-investor-relations-website-302449085.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/haemonetics-4th-quarter-and-fiscal-year-2025-earnings-release-available-on-investor-relations-website-302449085.html<\/a><\/p>\n<p>SOURCE  Haemonetics Corporation<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NE82651&amp;Transmission_Id=202505080600PR_NEWS_USPR_____NE82651&amp;DateId=20250508\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire Financial release accessible online BOSTON , May 8, 2025 \/PRNewswire\/ &#8212;\u00a0Haemonetics Corporation (NYSE: HAE) announced that financial results for its fourth quarter and fiscal year 2025, which ended March 29, 2025, are available on its Investor Relations website. The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on May 8, 2025. The conference call and webcast can be accessed with the following information: Teleconference link: https:\/\/register-conf.media-server.com\/register\/BI8b22e12b203a4693bead05f6d9f68d5d Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start. A &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-4th-quarter-and-fiscal-year-2025-earnings-release-available-on-investor-relations-website\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Haemonetics 4th Quarter and Fiscal Year 2025 Earnings Release Available on Investor Relations Website&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-848904","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Haemonetics 4th Quarter and Fiscal Year 2025 Earnings Release Available on Investor Relations Website - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-4th-quarter-and-fiscal-year-2025-earnings-release-available-on-investor-relations-website\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Haemonetics 4th Quarter and Fiscal Year 2025 Earnings Release Available on Investor Relations Website - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire Financial release accessible online BOSTON , May 8, 2025 \/PRNewswire\/ &#8212;\u00a0Haemonetics Corporation (NYSE: HAE) announced that financial results for its fourth quarter and fiscal year 2025, which ended March 29, 2025, are available on its Investor Relations website. The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on May 8, 2025. The conference call and webcast can be accessed with the following information: Teleconference link: https:\/\/register-conf.media-server.com\/register\/BI8b22e12b203a4693bead05f6d9f68d5d Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start. A &hellip; Continue reading &quot;Haemonetics 4th Quarter and Fiscal Year 2025 Earnings Release Available on Investor Relations Website&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-4th-quarter-and-fiscal-year-2025-earnings-release-available-on-investor-relations-website\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-08T10:04:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/351568\/Haemonetics_Corporation_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-4th-quarter-and-fiscal-year-2025-earnings-release-available-on-investor-relations-website\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-4th-quarter-and-fiscal-year-2025-earnings-release-available-on-investor-relations-website\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Haemonetics 4th Quarter and Fiscal Year 2025 Earnings Release Available on Investor Relations Website\",\"datePublished\":\"2025-05-08T10:04:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-4th-quarter-and-fiscal-year-2025-earnings-release-available-on-investor-relations-website\\\/\"},\"wordCount\":408,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-4th-quarter-and-fiscal-year-2025-earnings-release-available-on-investor-relations-website\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/351568\\\/Haemonetics_Corporation_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-4th-quarter-and-fiscal-year-2025-earnings-release-available-on-investor-relations-website\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-4th-quarter-and-fiscal-year-2025-earnings-release-available-on-investor-relations-website\\\/\",\"name\":\"Haemonetics 4th Quarter and Fiscal Year 2025 Earnings Release Available on Investor Relations Website - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-4th-quarter-and-fiscal-year-2025-earnings-release-available-on-investor-relations-website\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-4th-quarter-and-fiscal-year-2025-earnings-release-available-on-investor-relations-website\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/351568\\\/Haemonetics_Corporation_Logo.jpg\",\"datePublished\":\"2025-05-08T10:04:16+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-4th-quarter-and-fiscal-year-2025-earnings-release-available-on-investor-relations-website\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-4th-quarter-and-fiscal-year-2025-earnings-release-available-on-investor-relations-website\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-4th-quarter-and-fiscal-year-2025-earnings-release-available-on-investor-relations-website\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/351568\\\/Haemonetics_Corporation_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/351568\\\/Haemonetics_Corporation_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-4th-quarter-and-fiscal-year-2025-earnings-release-available-on-investor-relations-website\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Haemonetics 4th Quarter and Fiscal Year 2025 Earnings Release Available on Investor Relations Website\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Haemonetics 4th Quarter and Fiscal Year 2025 Earnings Release Available on Investor Relations Website - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-4th-quarter-and-fiscal-year-2025-earnings-release-available-on-investor-relations-website\/","og_locale":"en_US","og_type":"article","og_title":"Haemonetics 4th Quarter and Fiscal Year 2025 Earnings Release Available on Investor Relations Website - Market Newsdesk","og_description":"PR Newswire Financial release accessible online BOSTON , May 8, 2025 \/PRNewswire\/ &#8212;\u00a0Haemonetics Corporation (NYSE: HAE) announced that financial results for its fourth quarter and fiscal year 2025, which ended March 29, 2025, are available on its Investor Relations website. The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on May 8, 2025. The conference call and webcast can be accessed with the following information: Teleconference link: https:\/\/register-conf.media-server.com\/register\/BI8b22e12b203a4693bead05f6d9f68d5d Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start. A &hellip; Continue reading \"Haemonetics 4th Quarter and Fiscal Year 2025 Earnings Release Available on Investor Relations Website\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-4th-quarter-and-fiscal-year-2025-earnings-release-available-on-investor-relations-website\/","og_site_name":"Market Newsdesk","article_published_time":"2025-05-08T10:04:16+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/351568\/Haemonetics_Corporation_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-4th-quarter-and-fiscal-year-2025-earnings-release-available-on-investor-relations-website\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-4th-quarter-and-fiscal-year-2025-earnings-release-available-on-investor-relations-website\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Haemonetics 4th Quarter and Fiscal Year 2025 Earnings Release Available on Investor Relations Website","datePublished":"2025-05-08T10:04:16+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-4th-quarter-and-fiscal-year-2025-earnings-release-available-on-investor-relations-website\/"},"wordCount":408,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-4th-quarter-and-fiscal-year-2025-earnings-release-available-on-investor-relations-website\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/351568\/Haemonetics_Corporation_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-4th-quarter-and-fiscal-year-2025-earnings-release-available-on-investor-relations-website\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-4th-quarter-and-fiscal-year-2025-earnings-release-available-on-investor-relations-website\/","name":"Haemonetics 4th Quarter and Fiscal Year 2025 Earnings Release Available on Investor Relations Website - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-4th-quarter-and-fiscal-year-2025-earnings-release-available-on-investor-relations-website\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-4th-quarter-and-fiscal-year-2025-earnings-release-available-on-investor-relations-website\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/351568\/Haemonetics_Corporation_Logo.jpg","datePublished":"2025-05-08T10:04:16+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-4th-quarter-and-fiscal-year-2025-earnings-release-available-on-investor-relations-website\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-4th-quarter-and-fiscal-year-2025-earnings-release-available-on-investor-relations-website\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-4th-quarter-and-fiscal-year-2025-earnings-release-available-on-investor-relations-website\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/351568\/Haemonetics_Corporation_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/351568\/Haemonetics_Corporation_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-4th-quarter-and-fiscal-year-2025-earnings-release-available-on-investor-relations-website\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Haemonetics 4th Quarter and Fiscal Year 2025 Earnings Release Available on Investor Relations Website"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/848904","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=848904"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/848904\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=848904"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=848904"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=848904"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}